Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.

HKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$5.965
+HK$0.035 · +0.59%
Latest quote
HK$5.965
+HK$0.035 · +0.59%
Regular session · HKT · Market data may be delayed.
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.
Day range
Current HK$5.965
52-week range
Current HK$5.965
Regular session · HKT · Market data may be delayed.
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.
Day range
Current HK$5.965
52-week range
Current HK$5.965
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.51B HKD | 1.61B HKD | 1.52B HKD | 1.73B HKD | 1.56B HKD |
| Cost of goods sold | 587.78M HKD | 546.32M HKD | 477.7M HKD | 580.96M HKD | 436.54M HKD |
| Gross profit | 925.58M HKD | 1.07B HKD | 1.05B HKD | 1.15B HKD | 1.12B HKD |
| Research and development | 11.62M HKD | 9.13M HKD | 12.21M HKD | 7.7M HKD | 11.27M HKD |
| Selling, general, and administrative | 390.41M HKD | 492M HKD | 410.29M HKD | 341.68M HKD | 341.68M HKD |
| Operating expenses | 453.34M HKD | 488.41M HKD | 423.09M HKD | 338.57M HKD | 341.16M HKD |
| Interest income | 46.84M HKD | 57.27M HKD | 72.88M HKD | 20.59M HKD | 4.38M HKD |
| Interest expense | 5.66M HKD | 6.48M HKD | 5.98M HKD | 4.66M HKD | 4.71M HKD |
| Depreciation and amortization | 19.53M HKD | 88.12M HKD | 82.51M HKD | 75.47M HKD | 69.97M HKD |
| Operating income | 472.24M HKD | 576.92M HKD | 624.15M HKD | 811.58M HKD | 778.46M HKD |
| Net income | 397.22M HKD | 500.28M HKD | 540.39M HKD | 645.88M HKD | 607.84M HKD |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.35
2025 complete year+45.8% since 2021
2026 partial: HK$0.40
HK$0.24
2,021
HK$0.53
2,022
HK$0.33
2,023
HK$0.33
2,024
HK$0.35
2,025
HK$0.40
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jun 12, 2026 | HK$0.40Special | Jun 15, 2026 | Jun 26, 2026 |
Dividend | Jun 5, 2025 | HK$0.35Irregular | Jun 6, 2025 | Jun 18, 2025 |
Dividend | Jun 12, 2024 | HK$0.33Annual | Jun 13, 2024 | Jun 24, 2024 |
Dividend | May 10, 2023 | HK$0.33Annual | May 11, 2023 | May 31, 2023 |
Dividend | Oct 6, 2022 | HK$0.25Special | Oct 7, 2022 | Oct 21, 2022 |
Dividend | Jun 14, 2022 | HK$0.28Annual | Jun 15, 2022 | Jun 30, 2022 |
Ex-dividend Jun 12, 2026
HK$0.40
Special
Record Jun 15, 2026 · Payment Jun 26, 2026
Ex-dividend Jun 5, 2025
HK$0.35
Irregular
Record Jun 6, 2025 · Payment Jun 18, 2025
Ex-dividend Jun 12, 2024
HK$0.33
Annual
Record Jun 13, 2024 · Payment Jun 24, 2024
Ex-dividend May 10, 2023
HK$0.33
Annual
Record May 11, 2023 · Payment May 31, 2023
Ex-dividend Oct 6, 2022
HK$0.25
Special
Record Oct 7, 2022 · Payment Oct 21, 2022
Ex-dividend Jun 14, 2022
HK$0.28
Annual
Record Jun 15, 2022 · Payment Jun 30, 2022
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS4.54M0.00%646.2B USD0.05%$88.41+0.50%
iShares Core MSCI Emerging Markets ETFIEMG3.28M0.00%161.18B USD0.09%$83.65+1.65%
Vanguard FTSE Developed Markets ETFVEA1.93M0.00%315B USD0.03%$73.76+0.44%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS768.26K0.01%13.6B USD0.06%$161.34+0.42%
Avantis Emerging Markets Equity ETFAVEM532.56K—28.22B USD0.33%$96.81+1.52%
Schwab International Small-Cap Equity ETFSCHC409.46K0.01%5.68B USD0.06%$51.62+0.27%
Vanguard FTSE Pacific ETFVPL289.19K0.00%13.1B USD0.07%$118.42+1.27%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM271.53K0.00%9.54B USD0.39%$41.00+1.36%
Vanguard Total International Stock ETFVXUS
iShares Core MSCI Emerging Markets ETFIEMG
Vanguard FTSE Developed Markets ETFVEA
Vanguard FTSE All-World ex-US Small-Cap ETFVSS
Avantis Emerging Markets Equity ETFAVEM
Schwab International Small-Cap Equity ETFSCHC
Vanguard FTSE Pacific ETFVPL
Dimensional - Emerging Markets Core Equity 2 ETFDFEMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.